Female Health ROA 2006-2020 | VERU

Current and historical return on assets (ROA) values for Female Health (VERU) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Female Health ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-06-30 $-0.01B $0.07B -17.39%
2020-03-31 $-0.01B $0.06B -18.26%
2019-12-31 $-0.01B $0.06B -24.30%
2019-09-30 $-0.01B $0.05B -22.75%
2019-06-30 $-0.02B $0.05B -33.17%
2019-03-31 $-0.02B $0.05B -43.14%
2018-12-31 $-0.02B $0.05B -41.71%
2018-09-30 $-0.02B $0.05B -45.71%
2018-06-30 $-0.02B $0.05B -38.71%
2018-03-31 $-0.01B $0.06B -25.34%
2017-12-31 $-0.01B $0.05B -21.82%
2017-09-30 $-0.01B $0.06B -15.65%
2017-06-30 $-0.01B $0.06B -11.21%
2017-03-31 $-0.00B $0.06B -8.08%
2016-12-31 $-0.00B $0.06B -4.42%
2016-09-30 $0.00B $0.04B 0.00%
2016-06-30 $0.00B $0.04B 7.64%
2016-03-31 $0.00B $0.04B 7.84%
2015-12-31 $0.01B $0.04B 13.42%
2015-09-30 $0.01B $0.04B 13.99%
2015-06-30 $0.00B $0.04B 8.70%
2015-03-31 $0.00B $0.04B 8.96%
2014-12-31 $0.00B $0.03B 3.05%
2014-09-30 $0.00B $0.03B 3.01%
2014-06-30 $0.01B $0.03B 26.47%
2014-03-31 $0.01B $0.03B 26.67%
2013-12-31 $0.01B $0.04B 35.56%
2013-09-30 $0.02B $0.04B 46.15%
2013-06-30 $0.02B $0.03B 51.20%
2013-03-31 $0.02B $0.03B 61.02%
2012-12-31 $0.02B $0.03B 62.96%
2012-09-30 $0.02B $0.03B 64.65%
2012-06-30 $0.01B $0.03B 59.09%
2012-03-31 $0.01B $0.02B 51.28%
2011-12-31 $0.01B $0.02B 45.07%
2011-09-30 $0.01B $0.02B 29.85%
2011-06-30 $0.01B $0.02B 36.36%
2011-03-31 $0.01B $0.02B 36.92%
2010-12-31 $0.01B $0.02B 49.23%
2010-09-30 $0.01B $0.02B 44.44%
2010-06-30 $0.00B $0.01B 18.75%
2010-03-31 $0.00B $0.02B 24.62%
2009-12-31 $0.00B $0.02B 25.81%
2009-09-30 $0.01B $0.02B 47.46%
2009-06-30 $0.01B $0.02B 51.85%
2009-03-31 $0.01B $0.01B 53.85%
2008-12-31 $0.01B $0.01B 46.15%
2008-09-30 $0.01B $0.01B 37.74%
2008-06-30 $0.00B $0.01B 32.00%
2008-03-31 $0.00B $0.01B 26.09%
2007-12-31 $0.00B $0.01B 19.05%
2007-09-30 $0.00B $0.01B 10.81%
2007-06-30 $0.00B $0.01B 0.00%
2007-03-31 $0.00B $0.01B 0.00%
2006-12-31 $0.00B $0.01B 0.00%
2006-09-30 $0.00B $0.01B 0.00%
2006-06-30 $0.00B $0.01B 0.00%
2006-03-31 $0.00B $0.01B 0.00%
2005-12-31 $0.00B $0.01B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.184B $0.032B
Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $178.682B 33.53
Medtronic (MDT) Ireland $136.129B 25.64
Stryker (SYK) United States $74.576B 28.92
Boston Scientific (BSX) United States $53.107B 30.68
Lonza Group Ag (LZAGY) Switzerland $45.620B 0.00
Baxter (BAX) United States $39.840B 24.37
Terumo (TRUMY) Japan $30.003B 38.35
Zimmer Biomet Holdings (ZBH) United States $27.355B 22.70
EssilorLuxottica Societe Anonyme (ESLOY) France $27.164B 0.00
ResMed (RMD) United States $24.364B 35.32
Sunny Optical Technology (SNPTF) China $17.659B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.383B 0.00
Bio-Rad Laboratories (BIO) United States $14.666B 66.33
Insulet (PODD) United States $14.217B 601.53
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.053B 42.66
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.140B 10.54
Hill-Rom Holdings (HRC) United States $5.406B 13.42
Canopy Growth (CGC) Canada $5.305B 0.00
Haemonetics (HAE) United States $4.393B 29.27
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.250B 0.00
Neogen (NEOG) United States $3.902B 63.97
ICU Medical (ICUI) United States $3.841B 29.31
Envista Holdings (NVST) United States $3.701B 25.24
Abcam (ABCZY) $3.220B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.058B 0.00
TG Therapeutics (TGTX) United States $3.007B 0.00
National Vision Holdings (EYE) United States $2.947B 458.00
NuVasive (NUVA) United States $2.507B 34.94
Agios Pharmaceuticals (AGIO) United States $2.341B 0.00
AtriCure (ATRC) United States $1.724B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.632B 148.92
NanoString Technologies (NSTG) United States $1.620B 0.00
Cardiovascular Systems (CSII) United States $1.415B 0.00
MacroGenics (MGNX) United States $1.336B 0.00
Owens & Minor (OMI) United States $1.295B 29.01
Aphria (APHA) Canada $1.218B 0.00
InMode (INMD) Israel $1.125B 28.37
Cerus (CERS) United States $0.980B 0.00
Quanterix (QTRX) United States $0.898B 0.00
PetIQ (PETQ) United States $0.882B 25.30
BioLife Solutions (BLFS) United States $0.835B 435.00
Lantheus Holdings (LNTH) United States $0.804B 11.14
OraSure Technologies (OSUR) United States $0.762B 0.00
Phibro Animal Health (PAHC) United States $0.713B 16.32
LeMaitre Vascular (LMAT) United States $0.685B 41.80
Meridian Bioscience (VIVO) United States $0.665B 15.36
Vapotherm (VAPO) United States $0.650B 0.00
Aurora Cannabis (ACB) Canada $0.600B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.560B 79.08
Zynex (ZYXI) United States $0.553B 48.27
Omeros (OMER) United States $0.536B 0.00
Surmodics (SRDX) United States $0.517B 56.72
VAREX IMAGING (VREX) United States $0.460B 19.93
Cytosorbents (CTSO) United States $0.327B 0.00
Viemed Healthcare (VMD) United States $0.325B 11.61
HEXO (HEXO) $0.312B 0.00
Utah Medical Products (UTMD) United States $0.285B 24.44
InfuSystems Holdings (INFU) United States $0.265B 50.42
Neptune Wellness Solutions (NEPT) Canada $0.242B 0.00
Surface Oncology (SURF) United States $0.240B 0.00
Organigram Holdings (OGI) Canada $0.210B 0.00
Chimerix (CMRX) United States $0.164B 0.00
Bovie Medical (APYX) United States $0.154B 0.00
Wound Management Technologies (SMTI) United States $0.152B 0.00
Fonar (FONR) United States $0.142B 12.58
Exagen (XGN) United States $0.137B 0.00
Liberty Health Sciences (LHSIF) United States $0.128B 0.00
Evolus (EOLS) United States $0.122B 0.00
Capricor Therapeutics (CAPR) United States $0.098B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.085B 0.00
Chembio Diagnostics (CEMI) United States $0.084B 0.00
Rockwell Medical (RMTI) United States $0.077B 0.00
United-Guardian (UG) United States $0.069B 15.39
Oramed Pharmaceuticals (ORMP) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.061B 0.00
MTech Acquisition (KERN) United States $0.051B 0.00
Nephros (NEPH) United States $0.050B 0.00
Trinity Biotech (TRIB) Ireland $0.048B 9.00
ImmuCell (ICCC) United States $0.039B 0.00
FSD PHARMA INC (HUGE) Canada $0.034B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.018B 0.00
Akers Biosciences Inc (AKER) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
NF Energy Saving (BIMI) China $0.016B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00